Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03020316 · ClinicalTrials.gov registry record · NA

Peer Mentored Approaches For Men And Women With Coronary Artery Disease ("4Steps")

A NA study, sponsored by Weill Medical College of Cornell University.

Completed
Registry status
NA
Development phase
72
Enrollment target

NCT03020316: Completed NA study, sponsored by Weill Medical College of Cornell University.

NCT03020316 is a NA study that has completed, run by Weill Medical College of Cornell University. The registered enrollment target is 72 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03020316, a NA study, has completed, sponsored by Weill Medical College of Cornell University.

COMPLETED
Registry status
NA
Development phase
72 participants
Enrollment target

Study Summary

This study will be a pilot prospective randomized study using a peer mentor with or without Transcendental Meditation as compared to usual care for men and women with a new diagnosis of coronary artery disease (CAD). The study is designed to explore between cohort comparisons of perceived stress and a number of additional outcomes. The results of this pilot study will be used in the design of larger future trials. The target population is adult men and women with a new diagnosis of CAD made on the basis of a myocardial infarction, coronary revascularization procedure, acute coronary syndrome, or imaging test suggestive of CAD. The overall hypothesis of this proposal is that the addition of a peer mentor and training in Transcendental Meditation to usual care will improve perceived stress and medication adherence for men and women with newly diagnosed CAD as compared with usual care.

Primary Outcome

Cohen Perceived Stress Scale (PSS-10) Each item is rated on a 5-point scale ranging from never (0) to almost always (4). Positively worded items are reverse scored, and the ratings are summed, with higher scores indicating more perceived stress. Total scale range: 0-40. Scores around 13 are considered average. Scores of 20 or higher are considered high stress.

Interventions

  • BEHAVIORAL Transcendental Meditation
  • BEHAVIORAL Peer Mentor

Trial Details

FieldValue
Enrollment Target 72 participants
Start Date 2016-04
Est. Completion 2019-11-22
Phase NA

What the finished NCT03020316 record still lists

NCT03020316 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 72 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower).

The record links to 0 conditions, and to 2 interventions - of which Transcendental Meditation is the first listed.

NCT03020316 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT03020316 about?

NCT03020316 is a clinical study titled "Peer Mentored Approaches For Men And Women With Coronary Artery Disease ("4Steps")". This study will be a pilot prospective randomized study using a peer mentor with or without Transcendental Meditation as compared to usual care for men and women with a new diagnosis of coronary artery disease (CAD). The study is designed to explore between cohort comparisons of perceived stress and...

What is the current status of trial NCT03020316?

This trial is currently completed. It is a NA study. The enrollment target is 72 participants. The study started on 2016-04. Estimated completion is 2019-11-22.

What interventions are being tested in trial NCT03020316?

The interventions under investigation include: Transcendental Meditation (BEHAVIORAL), Peer Mentor (BEHAVIORAL).

Who is sponsoring clinical trial NCT03020316?

This trial is sponsored by Weill Medical College of Cornell University, which has 701 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT03020316's enrollment target sits among peer trials

72 1089th of 2000 higher than 899 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02359253 · 72 participants · NA

    Robot Aided Rehabilitation - Intervention

  • NCT02962661 · 72 participants · Phase 1

    Donor Bone Marrow Derived Mesenchymal Stem Cells in Controlling Heart Failure in Patients With Cardiomyopathy Caused by Anthracyclines

  • NCT03113643 · 72 participants · Phase 1

    SL-401 in Combination With Azacitidine or Azacitidine/Venetoclax in Acute Myeloid Leukemia (AML), High-Risk Myelodysplastic Syndrome (MDS) or Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)

  • NCT03187535 · 72 participants · NA

    Effect of TEAS on PONV After Spinal Surgery

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT03020316, the US trial registry maintained by the National Library of Medicine. NCT03020316 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.